Stock Analysis
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)SNY
Sector: Healthcare · Industry: Drug Manufacturers - General
AnalystsBuy30 analystsPrice is 11% of the way from the year's low to its high.
PMP Verdict
Insufficient financial data
No financial statements on file for this ticker — fundamental scores are not computed.
Bull Case
- ✓Interest coverage 20.2× — debt well covered
What's happening with SNY
About Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Show more
Although the company offers a diverse array of drugs, its highest-revenue product, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
Employees: 74,846 · Website ↗
Price History
Weekly Candlestick Chart — up to 5Y
Key Metrics
Financial snapshot · Tap any metric for its definition and grade
Valuation
55CP/E (TTM)—
Price / TTM EPS (own statements)
P/FCF12.1xA
Grade A: CheapPrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative
FCF Yield8.2%A
Grade A: ValueInverse of Finnhub P/FCF (own TTM FCF unavailable)
P/S (TTM)1.76xA
Grade A: CheapPrice / TTM Revenue (own statements)
EV/EBITDA13.2xB
Grade B: FairEnterprise value / EBITDA (Finnhub) — capital-structure neutral
EV/Sales2.1xB
Grade B: FairEnterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple
Forward P/E8.2xA
Grade A: CheapPrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth
P/B Ratio1.32xA
Grade A: FairPrice to Book Value. Neg. equity = heavy buybacks
PEG Ratio2.79C
Grade C: ExpensiveFinnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)
Dividend Yield11.25%C
Grade C: HighTTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress
Payout Ratio244.9%D
Grade D: UnsustainableDividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable
Profitability
25EROIC—
NOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat
ROE5.6%D
Grade D: WeakReturn on Equity. Neg. equity = heavy buybacks
ROA3.1%D
Grade D: WeakReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit
Net Margin8.1%C
Grade C: AverageNet Income / Revenue
Operating Margin—
TTM EBIT / TTM Revenue
Gross Margin72.8%A
Grade A: PremiumGross Profit / Revenue
FCF Margin—
FCF / Revenue
True FCF Margin—
TTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost
Growth
0ERevenue CAGR—
Compound annual revenue growth (up to 5Y depending on data availability)
Net Income CAGR—
Compound annual net income growth (up to 5Y depending on data availability)
EPS CAGR (5Y)—
Compound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0
Implied EPS Growth—
Analyst forward EPS (normalized basis) vs our GAAP TTM EPS — different bases, so extreme values usually mark cyclically depressed TTM earnings, not real growth
Dilution (5Y)—
Share count change over 5Y
SBC / Net Income—
Stock-based comp/Net income. >30% = dilution risk
SBC / Revenue—
TTM stock-based comp / TTM Revenue
Financial Health
31DAltman Z-Score—
Bankruptcy risk. >3 Safe, <1.8 Distress
Current Ratio0.99xD
Grade D: LowCurrent Assets/Liabilities
Quick Ratio0.64xC
Grade C: Ok(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory
Interest Coverage20.2xA
Grade A: StrongEBIT/Interest. >10 Strong
Debt Repayment—
Years to repay net debt via FCF
Net Debt/EBIT—
Leverage. <2x Low, >4x High
Debt/Equity0.34xA
Grade A: LowDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.
Cash / Debt—
Cash covers how much of total debt. >1 = could repay all debt from cash
Quality
0EPiotroski F-Score—
Financial strength 0–9. >7 Strong
Beneish M-Score—
Earnings manipulation risk. < -2.22 Safe
FCF Conversion—
FCF / Net Income
Margin Stability—
EBIT margin std deviation. Lower = stable
Capex / Revenue—
TTM CapEx / TTM Revenue — high % = capital-hungry business
Asset Turnover0.38xD
Grade D: LowRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales
More metrics — Moat, Per Share, Balance Sheet, MarketHide additional metrics
Moat
0EROIC >12% Years—
Share of completed fiscal years with ROIC > 12% — measures multi-year capital-return durability
Gross Margin (Med.)—
Median annual gross margin across available fiscal years — pricing-power durability
FCF-Positive Years—
Share of completed fiscal years with positive free cash flow
Net Margin Floor—
Weakest annual net margin across completed fiscal years — recession/downcycle resilience
Per Share
EPS (TTM)—
TTM net income per share (Finnhub fallback)
Cash / Share$5.30
Cash & short-term investments per share (Finnhub)
Book Value / Share$57.77
Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks
Balance Sheet
Total Debt—
Total debt obligations (short + long term)
Cash & Equiv.—
Cash and short-term investments
Net Debt—
Total Debt minus Cash. Negative = Net Cash position
Total Equity—
Shareholders' equity (book value)
Asset / Liability—
Total Assets / Total Liabilities
Market
Market Cap$97.19B
Current Market Capitalization
Beta0.58B
Grade B: DefensivePrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings
How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.
Ratio snapshot Oct 17, 2026
Key Insights: Sanofi American Depositary Shares (Each representing one-half of one ordinary share) (SNY)
SNY is up 0.79% at the last close.
- The stock currently yields 11.3% in dividends.
See how SNY ranks on the Capex Tracker — top 50 capital spenders compared.
Recent Market Moves
See all SNY moves →Frequently Asked Questions about SNY
What is the current Sanofi American Depositary Shares (Each representing one-half of one ordinary share) (SNY) stock price?
SNY is trading at $40.61 at the last market close, up 0.79% on the session. PreMarketPrice tracks SNY pre-market, intraday and after-hours prices.
Is SNY stock a buy right now?
PreMarketPrice's quantitative model rates Sanofi American Depositary Shares (Each representing one-half of one ordinary share)'s financial health at 31/100. This is a data-driven snapshot of fundamentals, not investment advice.
Is SNY stock overvalued?
Sanofi American Depositary Shares (Each representing one-half of one ordinary share) trades at a trailing P/E of n/a and our valuation score rates it 55/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.
When does Sanofi American Depositary Shares (Each representing one-half of one ordinary share) report earnings?
No confirmed earnings date is currently scheduled for SNY. The Earnings section lists recent reports and updates as dates are announced.
What sector does Sanofi American Depositary Shares (Each representing one-half of one ordinary share) operate in?
Sanofi American Depositary Shares (Each representing one-half of one ordinary share) operates in the Healthcare sector, within the Drug Manufacturers - General industry. The Related Stocks section lists sector peers for comparison.
What does Sanofi American Depositary Shares (Each representing one-half of one ordinary share) do?
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases.
About Sanofi American Depositary Shares (Each representing one-half of one ordinary share) (SNY) Stock
Sanofi American Depositary Shares (Each representing one-half of one ordinary share) (SNY) is a US-listed stock operating in the Healthcare sector, specifically the Drug Manufacturers - General industry. As of the latest update, Sanofi American Depositary Shares (Each representing one-half of one ordinary share) is trading at $40.61, up 0.79% on the day with a market capitalization of $97.2 billion. The financial health score for SNY is 31/100, which indicates weak financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for SNY stock.
SNY Stock Analysis & Key Metrics
On PreMarketPrice, you can track Sanofi American Depositary Shares (Each representing one-half of one ordinary share) (SNY) across multiple dimensions:
- Pre-market price & movement: Real-time SNY stock price with percentage change, updated continuously during pre-market and regular trading hours.
- Valuation & P/E history: Historical P/E, P/S, and P/B ratios for SNY with trend analysis and normalized valuation multiples.
- Financial statements: Revenue, net income, assets, liabilities, and equity for Sanofi American Depositary Shares (Each representing one-half of one ordinary share) across multiple reporting periods.
- Financial health score: A composite score of 31/100 based on Altman Z-Score, Piotroski F-Score, profitability, and leverage metrics for SNY.
- Sector peers: Compare SNY against 4 other healthcare stocks on key financial metrics.
Is SNY a Good Stock to Buy?
This page provides data-driven analysis to help you evaluate Sanofi American Depositary Shares (Each representing one-half of one ordinary share) (SNY) as an investment. The financial health score of 31/100 suggests weak financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.
Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.Sanofi American Depositary Shares (Each representing one-half of one ordinary share) (SNY) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.